Stockholm - Delayed Quote SEK
Getinge AB (publ) (GETI-B.ST)
At close: October 25 at 5:29 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
33,591,000.00
31,827,000.00
28,291,000.00
27,049,000.00
29,819,000.00
Cost of Revenue
18,206,000.00
17,332,000.00
14,882,000.00
13,469,000.00
15,097,000.00
Gross Profit
15,385,000.00
14,495,000.00
13,410,000.00
13,580,000.00
14,722,000.00
Operating Expense
11,977,000.00
10,346,000.00
9,527,000.00
9,314,000.00
9,666,000.00
Operating Income
3,408,000.00
4,149,000.00
3,883,000.00
4,266,000.00
5,056,000.00
Net Non Operating Interest Income Expense
-527,000.00
-370,000.00
-174,000.00
-183,000.00
-288,000.00
Pretax Income
2,357,000.00
3,343,000.00
3,472,000.00
4,188,000.00
4,485,000.00
Tax Provision
652,000.00
915,000.00
956,000.00
1,187,000.00
1,213,000.00
Net Income Common Stockholders
1,691,000.00
2,412,000.00
2,491,000.00
2,970,000.00
3,239,000.00
Diluted NI Available to Com Stockholders
1,691,000.00
2,412,000.00
2,491,000.00
2,970,000.00
3,239,000.00
Basic EPS
6.22
8.86
9.15
10.90
11.89
Diluted EPS
6.22
8.86
9.15
10.90
11.89
Basic Average Shares
272,369.57
272,369.57
272,369.57
272,369.57
272,369.57
Diluted Average Shares
272,369.57
272,369.57
272,369.57
272,369.57
272,369.57
Total Operating Income as Reported
2,906,000.00
3,736,000.00
3,626,000.00
4,371,000.00
4,784,000.00
Total Expenses
30,183,000.00
27,678,000.00
24,409,000.00
22,783,000.00
24,763,000.00
Net Income from Continuing & Discontinued Operation
1,691,000.00
2,412,000.00
2,491,000.00
2,970,000.00
3,239,000.00
Normalized Income
1,934,054.73
2,591,322.00
2,661,375.00
2,980,032.00
3,387,097.21
Interest Income
--
123,000.00
54,000.00
10,000.00
5,000.00
Interest Expense
--
469,000.00
205,000.00
152,000.00
251,000.00
Net Interest Income
-527,000.00
-370,000.00
-174,000.00
-183,000.00
-288,000.00
EBIT
3,071,000.00
3,812,000.00
3,677,000.00
4,340,000.00
4,736,000.00
EBITDA
5,159,000.00
5,905,000.00
5,704,000.00
6,154,000.00
7,203,000.00
Reconciled Cost of Revenue
18,206,000.00
17,332,000.00
14,882,000.00
13,469,000.00
15,097,000.00
Reconciled Depreciation
2,088,000.00
2,093,000.00
2,027,000.00
1,814,000.00
2,467,000.00
Net Income from Continuing Operation Net Minority Interest
1,691,000.00
2,412,000.00
2,491,000.00
2,970,000.00
3,239,000.00
Total Unusual Items Excluding Goodwill
-336,000.00
-247,000.00
-235,000.00
-14,000.00
-203,000.00
Total Unusual Items
-336,000.00
-247,000.00
-235,000.00
-14,000.00
-203,000.00
Normalized EBITDA
5,495,000.00
6,152,000.00
5,939,000.00
6,168,000.00
7,406,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-92,945.27
-67,678.00
-64,625.00
-3,968.00
-54,902.79
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EKTA-B.ST Elekta AB (publ)
68.75
-0.87%
PERP-B.ST Perpetua Medical AB (publ)
4.4500
-1.44%
PHI1.DE Koninklijke Philips N.V.
29.55
-0.51%
DRW8.DE Dr?gerwerk AG & Co. KGaA
42.80
+0.23%
ACIXF Acarix AB (publ)
0.0304
0.00%
IMP-A-SDB.ST Implantica AG
42.45
-0.59%
EPIS-B.ST Episurf Medical AB (publ)
0.1444
+9.73%
DEMANT.CO Demant A/S
269.80
-1.82%
DRW3.DE Dr?gerwerk AG & Co. KGaA
46.20
-1.28%
MEDI.OL Medistim ASA
171.00
+0.59%